Professor Stephen MacMahon AO
Stephen is one of the founders of The George Institute for Global Health, an architect of its global expansion and currently holds the position of Principal Director of The George Institute for Global Health (worldwide).
He also holds professorial appointments in medicine at UNSW Sydney and the University of Oxford (UK), where he is a Oxford Martin Senior Fellow. Stephen is an international authority on the causes, prevention and treatment of cardiovascular diseases and has a special interest is the management of chronic and complex conditions in resource-poor settings, particularly in the Asia-Pacific region.
In addition to his Institute and university appointments, Stephen has held several external appointments, including former Chair of the International Scientific Board of the UK BioBank. He is also Executive Chair of George Clinical Pty Ltd, a wholly owned subsidiary of The George Institute. He sits on the Boards of several other not-for-profit organisations, including the Oxford Health Alliance.
Stephen has published more than 300 scientific papers and delivered more than 200 invited lectures. For his work in the field of cardiovascular disease, he has received numerous awards, fellowships and honours from various governments, universities and learned societies.
Professor Robyn Norton AO
Robyn Norton is co-founder and Principal Director of The George Institute for Global Health. She is Professor of Global Health & Oxford Martin Senior Fellow, University of Oxford; Professor of Public Health, Faculty of Medicine, UNSW Sydney; and Honorary Professor at Peking University.
Professor Norton has published widely and is internationally regarded for her research on the causes, prevention and management of injuries, especially road traffic and fall-related injuries, as well as the management of various critical conditions in surgical and intensive care settings. She was the inaugural Chair and is now Chair Emeritus of the Road Traffic Injuries Research Network, a network supported by the World Bank and the WHO, aimed at building research capacity and research agendas, to address the growing burden of road traffic injuries in low and middle-income countries.
She has had a long-standing commitment to improving women’s health and currently leads The George Institute’s research, implementation and advocacy efforts, aimed at improving the health of women and girls worldwide. Most recently she was the lead author on a University of Oxford supported policy paper entitled “Women’s Health: A New Global Agenda”, calling for a greater focus on addressing the burden of non-communicable diseases in women and the importance of a gendered approach to the collection and utilisation of health data.
此外，Robyn教授长期致力于改善妇女健康，她是《妇女健康: 全新全球议程(Women’s Health: A New Global Agenda)》政策文件的主要作者。报告由英国牛津大学发布，其目的是提高慢性病防控在妇女健康议程中的比重，并且呼吁使用性别分类方法来实施健康数据分析，从医疗卫生角度减少性别不平等。作为推动妇女健康议程全球对话的系列报告开篇之作，最终目标是通过驱使政策转变以挽救更多生命。
Professor Anushka Patel
Anushka is a Professor of Medicine, UNSW Sydney and a cardiologist at Royal Prince Alfred Hospital in Sydney, Australia. She undertook her medical training at the University of Queensland, with subsequent postgraduate research degrees from Harvard University and the University of Sydney.
As the Chief Scientist of the George Institute for Global Health, she has a key role in developing and supporting global strategic initiatives across the organisation. Her personal research interests focus on developing innovative solutions for delivering affordable and effective cardiovascular care in the community and in acute care hospital settings.
Anushka currently leads research projects relating to these interests in a number of countries including Australia, China and India. She is supported by a Principal Research Fellowship from the Australian National Health and Medical Research Council (NHMRC).
Professor Yangfeng WU - 武阳丰教授
Yangfeng is the Professorial Fellow of the Peking University Clinical Research Institute and Professor of Epidemiology in the Department of Epidemiology and Biostatistics at the Peking University School of Public Health. After receiving his undergraduate and graduate training in medicine, public health and epidemiology, Dr Wu started his career as a Research Fellow in the US-PRC Collaborative Study of Cardiovascular and Cardiopulmonary Epidemiology, where he was sent to the US later on through the NIH Scholar Exchange Program for training in epidemiological research.
His research focuses on prevention and control of cardiovascular disease and he has published over 150 peer-reviewed papers in both Chinese and international journals. As a cardiovascular expert, Professor Wu has made valuable contributions to reduce the impact of cardiovascular disease in China.
In 2009, he founded the China International Center for Chronic Disease Prevention in Beijing, a network of 12 Chinese and international research institutions, with the funding awarded by the National Heart, Lung and Blood Institute and the UnitedHealth Group. Through the platform, a large project on low-cost, simple interventions for blood pressure control and stroke prevention involving 120 villages from 10 counties in 5 provinces of China is currently running.
Besides his own research, he made great efforts to develop research platforms for high quality clinical research in China. He is the funding Director of The George Institute for Global Health, China, which is hosting the China International Center for Chronic Disease Prevention. He is also one of the founders of Peking University Clinical Research Institute, the first of its kind in China to provide professional technical support to clinical experts in designing, implementing and analyzing clinical studies.
He is also one of the founders of the Chinese Course on Innovative Drug Development and Regulatory Sciences, an international joint program hosted by Peking University Clinical Research Institute, in collaboration with University of Basal and the University of California at San Francisco. With his advices and suggestions, Peking University Clinical Research Program was launched in 2010, as an innovative model, to support financially, technically and also ethically the innovative ideas in clinical research.
As a Member of the Board, he actively participated in the establishment of the Peking University Health Science Center – University of Michigan Health System Joint Institute of Clinical and Translational Research, another new model of collaboration to promote high quality of clinical research in China. Under his leadership, a new graduate course “Expert Seminar Series on Sciences in Clinical Research” has been launched at Peking University Graduate School in September, 2011 to provide the students the most practice-relevant and advanced knowledge in clinical research. After three years of hard efforts, a system for high quality clinical research including resources for funding, technical supporting, scientific and ethical quality management, training, and administration has been established and started functioning.
Professor Vivekanand Jha
Professor Vivekanand Jha is the Executive Director at The George Institute for Global Health, India, a James Martin Fellow at The George Institute for Global Health, University of Oxford, and the President-Elect of the International Society of Nephrology.
Professor Jha has wide-ranging research interests, including understanding the health and societal impact of kidney diseases around the world and development of affordable, scalable and sustainable primary and secondary prevention tools. He has worked with many organisations including with WHO to develop clinical practice guidelines and advocacy papers, has lectured extensively around the world, and is a prolific writer and editor.
Professor Vlado Perkovic
Vlado Perkovic is Professor of Medicine at UNSW Sydney, and a Staff Specialist in Nephrology at the Royal North Shore Hospital.
His research focus is in clinical trials and epidemiology, in particular in preventing the progression of kidney disease and its complications. He leads several international clinical trials, and has been involved in developing Australian and global treatment guidelines. He has played a central role in the development of an affordable dialysis system, which was a Eureka Prize finalist in 2017.
Vlado is a member of the National Health and Medical Research Council Principal Committee on Research Translation, and is on the Board of the Australian Clinical Trials Alliance and the Association of Australian Medical Research Institutes. He is Chair of the International Society of Nephrology Advancing Clinical Trials (ISN-ACT) group; and is a Fellow of the Royal Australasian College of Physicians, and the Australian Academy of Health and Medical Sciences. He serves on the Editorial Boards of a number of leading specialist and general journals, including the Journal of the American Society of Nephrology, Circulation, and the New England Journal of Medicine.
Professor Anthony Rodgers
Professor Rodgers has a track record in cardiovascular disease prevention, innovation and public-private partnerships, with an interest in scale-able interventions to address major risks to health. He is currently Acting Director of the Cardiovascular Division at The George Institute, Australia.
After graduating in medicine in the United Kingdom he trained in epidemiology and public health in New Zealand. He was the Principal Author of the 2002 World Health Report, the main annual publication for WHO. Professor Rodgers has led developments of an affordable four-in-one cardiovascular combination pill ('polypill'). He led a clinical trial program in economically developed and developing countries, funded by the Wellcome Trust, European Union and others.
Professor Rodgers also developed a world first cell phone based smoking cessation programme for youth, which disseminated proven health support messages in an age-appropriate, affordable medium. Over 6,000 patients were involved in clinical trials that demonstrated a 50% increase in quit rates. The service has been rolled out by Departments of Health in NZ, UK and India, with over 2 million users to date. A follow-on program delivering cognitive behavioural therapy for depression prevention was successfully trialled among 1,200 at-risk teenagers.
Professor John Chalmers AC
John Chalmers has an outstanding record in hypertension research, both fundamental and clinical. His groundbreaking research on the role of the brain in the development of hypertension led to his election to Fellowship of the Australian Academy of Science and helped establish Flinders University as a leading international centre in hypertension and neuroscience research.
His studies on the treatment of high blood pressure for the prevention of heart attack and stroke have changed the way patients are treated throughout the world. His work has been recognised through many awards including the Wellcome Medal, the RT Hall Prize of the Cardiac Society of Australia and New Zealand, The Zanchetti Lifetime Achievement Award of the European Society of Hypertension and the Volhard Medal of the International Society of Hypertension.
He has been President or Chairman of the Australian Society of Medical Research, The Royal Australasian College of Physicians, the National Health and Medical Research Council of Australia, the WHO Expert Committee on Hypertension, the International Society of Hypertension and the Scientific Advisory Board of the World Heart Federation.
Professor Chalmers' contribution to medical science has been acknowledged through the award of many Honorary Doctoral degrees and extensive appointments on national and international boards and advisory committees. He was appointed a Companion in the Order of Australia (AC) in 1991 and an Officer in the National Order of Merit of France in 2010.
John Chalmers remains an active researcher at The George Institute Australia, where he is a principal investigator on many research grants and Chair of steering committees for major studies, mentors young clinical researchers from around the world, and continues to publish and lecture prolifically.
Professor Craig Anderson
Professor Craig Anderson is Professor of Neurology and Epidemiology, Faculty of Medicine, UNSW Sydney, and is in part-time clinical practice as a neurologist at Royal Prince Alfred Hospital, Sydney, Australia. He is Executive Director of The George Institute China at Peking University Health Science Center in Beijing, China.
Craig holds specialist qualifications in clinical neurology and geriatrics, a PhD in medicine and epidemiology from The University of Western Australia, and is a Senior Principal Research Fellow of the National Health and Medical Research Council (NHMRC) of Australia. He is a past President of the Asia Pacific Stroke Organisation and the Stroke Society of Australasia, and is a member of several specialist societies and an editor for the Cochrane Stroke Group. He has published widely on the clinical and epidemiological aspects of stroke, cardiovascular disease and aged care, and has led several large-scale investigator-initiated epidemiological and clinical trials that have had a major influence on clinical practice guidelines for stroke treatment and prevention.
Craig Anderson教授是乔治全球健康研究院（澳大利亚）神经与精神健康部门高级主管、乔治全球健康研究院（中国）所长、澳大利亚新南威尔士大学卒中医学与临床神经科学教授。Craig Anderson教授在临床神经学和老年保健学方面拥有专业资格，并在西澳大学获得医学和流行病学博士学位，他还是澳大利亚国家健康与医学研究委员会（NHMRC）高级主管研究员。
Professor Bruce Neal
Bruce Neal is Acting Executive Director at The George Institute for Global Health Australia; Professor of Medicine, UNSW Sydney; and Chair of the Australian Division of World Action on Salt and Health.
Dr Neal is a UK-trained physician who has 20 years research experience in the clinical, epidemiological, and public health fields with a focus on heart disease, stroke and diabetes. Bruce has a longstanding interest in the environmental determinants of high blood pressure and the potential for changes in the food supply to deliver health gains. His work has been characterised by its focus on collaboration, quantitation, translation and impact. He holds professorial appointments at UNSW Sydney, Imperial College London, Flinders University in South Australia, an honorary appointment at the University of Sydney and chairs the Australian Division of World Action on Salt and Health. He has published some 300 scientific papers and in 2016 was identified by Thomson Reuters as one of ‘The World’s Most Influential Scientific Minds’, an acknowledgement provided to just 3000 researchers across all disciplines, worldwide. He has particular expertise in salt reduction but also a broader knowledge of food policy issues related to sugars, fats, portion size and food labelling.
Professor Rebecca Ivers
Professor Rebecca Ivers is an injury epidemiologist and leading researcher in global health. Recognised for her expertise in studying injury, trauma care and falls prevention, Professor Ivers designs and leads large observational studies and randomised trials focusing on injury in high-risk and disadvantaged populations in Australia and in low- and middle-income countries in Asia.
Her work has substantially improved understanding relating to the burden of and risk factors for injury in many countries and informed policies for improving safety and reducing motor vehicle-related injury globally. She remains a passionate advocate for injury management and prevention. Her research in motorcycle safety has been influential in developing policy relating to motorcycle protective clothing and helmet use in high- and low- income settings and she has contributed chapters to multiple WHO good practice manuals on road safety. Her research on young drivers has influenced Australian government legislation on graduated driver licensing.
Professor Ivers also leads a program of work on prevention and care of injury in Aboriginal people. She says, “my team works closely with Aboriginal people and community organisations in various settings around Australia to understand the challenges and needs around road safety, injury and trauma care and to find ways to effect change. Our Driving Change program is one example”. Professor Ivers is member of the WHO Violence and Injury Prevention Mentor program and a member of the UN Road Safety Collaboration. In 2014 Professor Ivers was named in the Australian Financial Review and Westpac list of Australia’s Top 100 Women of Influence.
Awards and honours
- Winner, Innovation: Australian Financial Review and Westpac100 Women of Influence Awards 2014
- NSW Public Health Associations' Public Health Impact Award. July 2014
- Australian Injury Prevention Network (AIPN): 2013 AIPN Award for Sustained Achievement. November 2013
- Young Tall Poppy Award for Science.October 2008
- National Health and Medical Research Council Achievement Award. December 2007
Associate Professor Laurent Billot
Laurent is a senior biostatistician with 20 years of experience in health research. He is Director of the Statistics Division at the George Institute for Global Health and Associate Professor, Faculty of Medicine, UNSW Sydney.
He is responsible for providing statistical services to the George Institute and its collaborators in Australia and globally. He holds a Master of Science in Statistics and Computer Science and a Master of Research in Public Health (Biostatistics). He is an accredited statistician by the Statistical Society of Australia (AStat).
Professor Graham Hillis
Graham Hillis is Professor of Medicine (Cardiology), University of Western Australia and Head of Department of Cardiology, Royal Perth Hospital. His clinical and research interests include the echocardiography, the acute coronary syndromes, cardiac biomarkers and the prediction and management of perioperative cardiovascular complications in patients undergoing cardiac and major non-cardiac surgery.
Professor John Myburgh AO
Professor John A Myburgh AO, is Professor of Intensive Care Medicine, University of New South Wales; Director of the Critical Care Division at the George Institute for Global Health and Senior Intensive Care Physician at the St George Hospital, Sydney.
He holds an honorary Professorial appointment at the Monash University School of Public Health and Preventive Medicine.
He has an extensive research track record over 25 years and is regarded as a national and international expert in catecholamine neurophysiology and pharmacology, trials of clinical management of traumatic brain injury, fluid resuscitation and in the development and co-ordination of over 35 clinical trials in Intensive Care Medicine.
He has published over 230 refereed research publications, (including 12 papers in the New England Journal of Medicine) and 45 book chapters and monographs. His current h-index is 41, calculated from 221 publications in SCOPUS, yielding over 12000 citations, with a citation trajectory of 800 to 1500 citations per annum from 2010 to the present.
He has been a Chief Investigator on 16 Project Grants and 2 Enabling Grant; Associate Investigator on 5 Project Grants and 1 Centre of Research Excellence grant and was awarded 2 Practitioner Fellowships from the National Health and Medical Research Council for a total of over A$42M since 1998. In addition to 12 international and 25 institutional peer-reviewed grants and 5 unrestricted commercial grants, total cumulative research funding raised to the present is over A$77M.
He is a Foundation Member and Past-Chairman of the Australian and New Zealand Intensive Care Society Clinical Trials Group. He was instrumental in the establishment of the Australian and New Zealand Intensive Care Research Centre at the Monash University School of Public Health and Preventive Medicine.
In 2006, he was appointed to establish the Division of Critical Care and Trauma at the George Institute for Global Health and has developed programs of research including new opportunities for clinician-researchers that includes 14 PhD, post-doctoral and masters’ students and 10 Honorary positions.
He has delivered over 400 presentations at national and international scientific meetings since 1994, including over 50 plenary presentations at major scientific congresses.
He has received five major awards for research including the International Sepsis Forum Award in 2007, two University of New South Wales Research Excellence awards in 2010 and 2013. He was listed on the Australian and New Zealand Intensive Care Society Honour Roll in 2013 and National Health and Medical Research Council Peer Review Honour Roll in 2015.
He is current Secretary-General for the World Federation of Societies of Intensive and Critical Care Medicine.
He has reviewed manuscripts for 26 national and international journals (including the New England Journal of Medicine and Lancet) and sits on 2 journal editorial boards. He has assessed grants for 12 funding agencies including the National Health and Medical Research Council, the Medical Research Council of the United Kingdom and the Canadian Institute for Health Research.
In addition to his research profile, he has made a substantive contribution to education in Intensive Care Medicine, both at undergraduate and postgraduate levels over the last 25 years. He was instrumental in establishing the College of Intensive Care Medicine, serving as a Fellowship examiner for twelve years, on the Board for ten years and as the first elected President from 2010-2012.
In the 2014 Queen’s Birthday honours, he was made an Officer of the Order of Australia (AO) for distinguished service to medicine as an intensive care medical practitioner, educator and researcher, and as an international innovator in patient management.
In 2015, he was made a Fellow of the Australian Academy of Health and Medical Science.
In 2017, he was awarded the College of Intensive Care Medicine Medal.
In 2019, he was awarded a Doctor of Science (DSc) from the Faculty of Medicine, UNSW
Peter Dolnik is the Director, Centre for Operational and Research Excellence at The George Institute. His career has spanned both the academic and research management sectors. For a number of years, he had taught philosophy at various universities in Sydney and since 2000 he has worked in the area of research management at senior levels.
Key responsibilities associated with his latter role have included research-related compliance work, development of policies on research management as well as pre-award and post-award coordination of research funding.
Professor Lijing.L.YAN - 阎丽静教授
Professor YAN is the Honorary Professorial Fellow at The George Institute for Global Health at Peking University Health Science Center. She is also a researcher at the Health Economics and Management Institute, Guanghua School of Management, Peking University, Beijing, China and an adjunct associate professor at the Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
A bachelor degree holder from Peking University and a doctoral graduate of the University of California, Berkeley, she has experiences working in several American and Chinese academic institutions including the National Bureau of Economic Research, Northwestern University, and Peking University. Her main areas of research are chronic disease (cardiovascular disease and diabetes in particular) prevention and control, economic evaluations in health care, and integrated health management.
She is the Principal Investigator or Co-Investigator on a number of NHLBI-funded and China-funded research grants. She has published dozens of peer-reviewed scientific papers some of which in leading medical journals such as JAMA, Circulation, and Archives of Internal Medicine.
In her current capacity as the Director of the Chronic Disease Center, she oversees the research, capacity development, and advocacy activities for a large network of five international academic institutions and seven Chinese institutions in their concerted efforts to combat chronic diseases in China. The flagship project of the Center is the China Rural Health Initiative (LifeSeeds Program).
Dr Pallab K. Maulik
Pallab leads Research department at The George Institute for Global Health, India. He trained as a psychiatrist at All India Institute of Medical Sciences, New Delhi, received training in public health at the London School of Hygiene and Tropical Medicine, as well as Johns Hopkins School of Public Health where he pursued his Masters and Doctoral training. He brings a wealth of experience to the Institute, with an expertise in mental health.
Dr. Maulik has worked with the World Health Organisation (WHO), Geneva on Project Atlas and other mental health programs, and clinically as a psychiatrist in India and Australia.
His particular research interests include social determinants of health, especially mental health services, mental disorders, international mental health, and intellectual disability.
He is an Intermediate Career Wellcome Trust/DBT India Alliance Fellow and is leading a program called SMART Mental Health, which is on provision of mobile-based affordable evidence based mental health services in rural India.